PMID- 22325058 OWN - NLM STAT- MEDLINE DCOM- 20121108 LR - 20231213 IS - 1744-313X (Electronic) IS - 1744-3121 (Linking) VI - 39 IP - 4 DP - 2012 Aug TI - Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population. PG - 346-52 LID - 10.1111/j.1744-313X.2012.01097.x [doi] AB - Interleukin-18 (IL-18) is a potent proinflammatory cytokine, which can promote hepatitis B virus clearance. The latest studies find that genetic polymorphisms near the IL-28B gene are strongly associated with sustained viral response and spontaneous viral clearance in patients with chronically infected hepatitis C and hepatitis B. We investigated the effect of rs187238 and rs1946518 in IL-18 gene and rs8099917 in IL-28B gene on HBV recurrence in liver transplant patients. A total of 200 liver transplant recipients and relevant donors were enrolled in this study. The patients' mean follow-up was 39 month (range 10-65 month). All liver transplant recipients were in a stable stage. The total recipients (n = 200) were divided into end-stage liver disease secondary to hepatitis B (n = 140) and end-stage liver disease secondary to other diseases (n = 60) before transplantation. Recipients (n = 140) with hepatitis B before transplantation were defined to nonHBV recurrence group (n = 119) or HBV recurrence group (n = 21), which was positive for HBsAg or elevatory in HBV DNA (>2.0 x 10(2) IU mL(-1)) after transplantation. For the recipients (n = 140) had hepatitis B before transplantation, we studied the single-nucleotide polymorphisms (SNPs) of IL-18 gene (rs187238 and rs1946518) and IL-28B gene (rs8099917) by high-resolution melting (HRM) curve analysis. The serum levels of IL-18 and IFN-gamma were tested by ELISA. The serums levels of IFN-gamma were lower in HBV recurrence group than that in nonHBV recurrence group (P < 0.01). The genotype of IL-28B gene rs8099917 was associated with alanine aminotransferase (ALT) levels and aspartate aminotransferase (AST) levels in HBV-related liver transplant recipients (n = 140). The recipients with allele G (GG+GT) had higher ALT and AST levels (P < 0.05). No association was found between IL-18 gene and IL-28B gene polymorphisms with HBV recurrence in the liver transplant recipients or the donors. We identified that the IFN-gamma was a protective factor of HBV recurrence after liver transplantation. The allele G of rs8099917 was associated with hepatitis B-related hepatocytes injury. The rs8099917 G allele subgroup should reinforce antiviral therapy. CI - (c) 2012 Blackwell Publishing Ltd. FAU - Li, Y AU - Li Y AD - Department of Clinical Immunological Laboratory, West China Hospital, Sichuan University, Chengdu, China. FAU - Shi, Y AU - Shi Y FAU - Chen, J AU - Chen J FAU - Cai, B AU - Cai B FAU - Ying, B AU - Ying B FAU - Wang, L AU - Wang L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120210 PL - England TA - Int J Immunogenet JT - International journal of immunogenetics JID - 101232337 RN - 0 (DNA, Viral) RN - 0 (Hepatitis B Surface Antigens) RN - 0 (interferon-lambda, human) RN - 0 (Interleukin-18) RN - 0 (Interleukins) RN - 82115-62-6 (Interferon-gamma) RN - 9008-11-1 (Interferons) RN - EC 2.6.1.1 (Aspartate Aminotransferases) RN - EC 2.6.1.2 (Alanine Transaminase) SB - IM MH - Aged MH - Alanine Transaminase/blood MH - Alleles MH - Asian People/*genetics MH - Aspartate Aminotransferases/blood MH - Case-Control Studies MH - China/epidemiology MH - DNA, Viral/blood MH - Female MH - Follow-Up Studies MH - Gene Frequency MH - Genetic Association Studies MH - Genetic Predisposition to Disease MH - Genome, Human MH - Hepatitis B/*genetics/virology MH - Hepatitis B Surface Antigens/blood MH - Hepatitis B virus/pathogenicity MH - Humans MH - Interferon-gamma/blood MH - Interferons MH - Interleukin-18/*genetics MH - Interleukins/*genetics MH - Liver Transplantation/ethnology/*pathology MH - Male MH - Middle Aged MH - Polymorphism, Single Nucleotide MH - Promoter Regions, Genetic MH - Recurrence EDAT- 2012/02/14 06:00 MHDA- 2012/11/09 06:00 CRDT- 2012/02/14 06:00 PHST- 2012/02/14 06:00 [entrez] PHST- 2012/02/14 06:00 [pubmed] PHST- 2012/11/09 06:00 [medline] AID - 10.1111/j.1744-313X.2012.01097.x [doi] PST - ppublish SO - Int J Immunogenet. 2012 Aug;39(4):346-52. doi: 10.1111/j.1744-313X.2012.01097.x. Epub 2012 Feb 10.